产品封面图

GFPT1 Antibody Blocking Peptid

e(bs-13341P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-13341P
  • 2025年10月16日
    avatar
    品牌商
    10钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      500ug

    产品编号bs-13341P
    英文名称GFPT1 Antibody Blocking Peptide
    中文名称谷氨酰胺6-磷酸果糖转移酶封闭多肽
    英文别名D-fructose-6-phosphate amidotransferase 1; GFA; GFAT 1; GFAT; GFAT1; GFAT1m; GFPT; Gfpt1; GFPT1_HUMAN; Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 1; Glutamine--fructose-6-phosphate transaminase 1; Glutamine:fructose 6 phosphate amidotransferase 1; Hexosephosphate aminotransferase 1.
    纯化方法HPLC
    研究领域

    Metabolism > Pathways and Processes > Metabolic signaling pathways > Energy transfer pathways > Energy Metabolism

    Signal Transduction > Metabolism > Amino Acids

    Signal Transduction > Metabolism > Energy Metabolism

    亚基Homotetramer
    组织特异性Isoform 1 is predominantly expressed in skeletal muscle. Not expressed in brain. Seems to be selectively expressed in striated muscle.
    相似性Contains 1 glutamine amidotransferase type-2 domain.
    Contains 2 SIS domains.
    功能Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    注意事项This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
    背景资料Glutamine:fructose-6-phosphate amidotransferase (GFAT1) is the first and rate-limiting enzyme for the entry of glucose into the hexosamine biosynthesis pathway (HBP) in mammals. GFAT1, a member of the N-terminal nucleophile class of amidotransferases, converts fructose-6-phosphate into N-acetylglucosamine-6-phosphate. Hyperglycemia-induced insulin resistance, a condition in which exposure to high concentrations of glucose and insulin results in insulin resistance, may result from increased glucose metabolism through the HBP. Hypergylcemia-induced insulin resistance is a characteristic feature of type 2 diabetes. Consequently, GFAT1 is a potential therapeutic target in the treatment of type 2 diabetes.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥1680
    武汉博欧特生物科技有限公司
    2025年05月22日询价
    ¥1759.50
    深圳欣博盛生物科技有限公司
    2025年07月16日询价
    ¥3784.50
    西宝生物科技(上海)股份有限公司
    2025年07月04日询价
    ¥1
    瑞博奥(广州)生物科技股份有限公司
    2025年07月11日询价
    GFPT1 Antibody Blocking Peptide(bs-13341P)-500ug
    ¥880